CARVEDILOL

carvedilol 3.125 mg tablet, 30
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Moderate to severe heart failure

Restriction

Indication: Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 0 DPMQ: $17.53 Max safety net: $19.01 General Patient Charge: $21.80
Available brands
APO-Carvedilol
Carvidol
Vedilol 3.125
Volirop 3.125